April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
April 2026
The global chemical API CDMO market size was evaluated at USD 16.80 billion in 2025 and is predicted to hit around USD 40.88 billion by 2035, growing at a CAGR of 9.30%.
March 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
January 2026
The global investigational new drug CDMO market size is estimated to hit around USD 10.90 billion by 2035 from USD 5.61 billion in 2025, with a CAGR of 6.87%.
September 2025
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
September 2025
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global biomanufacturing specialty chemicals market is growing as demand rises for biologics, cell therapies, and advanced bioprocessing solutions.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
June 2026
The global orphan drugs market size was surpass to USD 216.55 billion in 2025 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
June 2026
The global drug-eluting balloon catheters market size was valued at USD 1.53 billion in 2025 and is expected to hit around USD 4.28 billion by 2035, growing at a CAGR of 10.83%.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 17.60 billion in 2025, with a CAGR of 3.60%.
June 2026
The global thin film drug manufacturing market size is estimated to hit around USD 15.50 billion by 2035, increasing from USD 7.93 billion in 2025, with a CAGR of 6.93%.
June 2026
The global dermatology drugs market size was calculated at USD 23.86 billion in 2025 and is projected to hit around USD 69 billion by 2035 with a CAGR of 11.2% .
June 2026
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The global CNS drug discovery market size was evaluated at USD 9.80 billion in 2025 and is predicted to hit around USD 27.55 billion by 2035, growing at a CAGR of 10.90%.
June 2026
The global subcutaneous drug delivery devices market size was valued at USD 36.12 billion in 2025 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
June 2026
The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.29 billion in 2025 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
June 2026
The global drug repurposing market size is estimated to hit around USD 62.24 billion by 2035, increasing from USD 36.87 billion in 2025, with a CAGR of 5.38%.
June 2026
The US cardiovascular drugs market size was evaluated at USD 28.42 billion in 2025 and is predicted to hit around USD 37.03 billion by 2035, growing at a CAGR of 2.68%.
June 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The global drug screening market size is exhibited at USD 10.55 billion in 2025 and is anticipated to attain around USD 43.72 billion by 2035 with a CAGR of 15.28%.
June 2026
The US drug discovery market size was evaluated at USD 26.24 billion in 2025 and is predicted to hit around USD 63.02 billion by 2035, growing at a CAGR of 9.16%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com